TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression

Tingting Song,* Hong Wang,* Yue Liu, Rongshan Cai, Dezhi Yang, Yongai Xiong Department of Pharmacy, Zunyi Medical University, Zunyi City, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongai Xiong Email yaxiong@zmu.edu.cnBackground:...

Full description

Bibliographic Details
Main Authors: Song T, Wang H, Liu Y, Cai R, Yang D, Xiong Y
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/tpgs-modified-long-circulating-liposomes-loading-ziyuglycoside-i-for-e-peer-reviewed-fulltext-article-IJN
_version_ 1818846079090688000
author Song T
Wang H
Liu Y
Cai R
Yang D
Xiong Y
author_facet Song T
Wang H
Liu Y
Cai R
Yang D
Xiong Y
author_sort Song T
collection DOAJ
description Tingting Song,* Hong Wang,* Yue Liu, Rongshan Cai, Dezhi Yang, Yongai Xiong Department of Pharmacy, Zunyi Medical University, Zunyi City, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongai Xiong Email yaxiong@zmu.edu.cnBackground: Ziyuglycoside I (ZgI), an active ingredient isolated from traditional Chinese medicine Sanguisorba officinalis L, has been demonstrated to increase the leucocytes and protect hematopoietic stem cells. However, the poor solubility and a short half-life of ZgI limit its bioavailability and efficacy. The D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) has been widely used to increase the solubility, improve the encapsulation rate, and extend the half-life of drugs.Methods: Here, we formulated the TPGS-modified long-circulating liposomes loading ZgI with a sustained drug release and enhanced therapy for myelosuppression. ZgI-TPGS-liposomes were manufactured using a thin-film hydration technique, followed by characterizations of physicochemical properties, including the particle size, zeta potential, TEM, SEM, FTIR, XRD, stability, drug loading (DL), encapsulation efficiency (EE). The in vitro and in vivo delivery efficiency were further evaluated by cellular uptake, in vitro drug release and in vivo pharmacokinetics. Finally, therapeutic effect on myelosuppression was investigated.Results: The ZgI-TPGS-liposomes had an particle size of 97.89 ± 1.42 nm and ZP of − 28.65 ± 0.16 mV. It exhibited DL of 9.06 ± 0.76% and EE of 92.34 ± 3.83%, along with excellent storage stability, cellular uptake and sustained drug release to free ZgI and liposomes without TPGS. Additionally, the TPGS modified liposomes significantly enhanced the therapeutic effect of ZgI on CTX induced myelosuppression, which can be confirmed in the apoptosis inhibition and cell viability promotion of CTX injured HSPC-1 cells. Also, the mice in vivo pharmacodynamics demonstrated that TPGS liposomes promoted ZgI increasing the numbers of leucocytes and neutrophils in myelosuppression mice induced by CTX.Conclusion: Our research suggest that TPGS-modified long-circulating liposomes loading ziyuglycoside I has potential application in myelosuppression therapy.Keywords: myelosuppression, therapy, TPGS, long-circulating liposomes, ziyuglycoside I
first_indexed 2024-12-19T05:39:51Z
format Article
id doaj.art-dca8e824ba264deeae8134aeb6c246b0
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-19T05:39:51Z
publishDate 2021-09-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-dca8e824ba264deeae8134aeb6c246b02022-12-21T20:34:03ZengDove Medical PressInternational Journal of Nanomedicine1178-20132021-09-01Volume 166281629568791TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of MyelosuppressionSong TWang HLiu YCai RYang DXiong YTingting Song,* Hong Wang,* Yue Liu, Rongshan Cai, Dezhi Yang, Yongai Xiong Department of Pharmacy, Zunyi Medical University, Zunyi City, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongai Xiong Email yaxiong@zmu.edu.cnBackground: Ziyuglycoside I (ZgI), an active ingredient isolated from traditional Chinese medicine Sanguisorba officinalis L, has been demonstrated to increase the leucocytes and protect hematopoietic stem cells. However, the poor solubility and a short half-life of ZgI limit its bioavailability and efficacy. The D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) has been widely used to increase the solubility, improve the encapsulation rate, and extend the half-life of drugs.Methods: Here, we formulated the TPGS-modified long-circulating liposomes loading ZgI with a sustained drug release and enhanced therapy for myelosuppression. ZgI-TPGS-liposomes were manufactured using a thin-film hydration technique, followed by characterizations of physicochemical properties, including the particle size, zeta potential, TEM, SEM, FTIR, XRD, stability, drug loading (DL), encapsulation efficiency (EE). The in vitro and in vivo delivery efficiency were further evaluated by cellular uptake, in vitro drug release and in vivo pharmacokinetics. Finally, therapeutic effect on myelosuppression was investigated.Results: The ZgI-TPGS-liposomes had an particle size of 97.89 ± 1.42 nm and ZP of − 28.65 ± 0.16 mV. It exhibited DL of 9.06 ± 0.76% and EE of 92.34 ± 3.83%, along with excellent storage stability, cellular uptake and sustained drug release to free ZgI and liposomes without TPGS. Additionally, the TPGS modified liposomes significantly enhanced the therapeutic effect of ZgI on CTX induced myelosuppression, which can be confirmed in the apoptosis inhibition and cell viability promotion of CTX injured HSPC-1 cells. Also, the mice in vivo pharmacodynamics demonstrated that TPGS liposomes promoted ZgI increasing the numbers of leucocytes and neutrophils in myelosuppression mice induced by CTX.Conclusion: Our research suggest that TPGS-modified long-circulating liposomes loading ziyuglycoside I has potential application in myelosuppression therapy.Keywords: myelosuppression, therapy, TPGS, long-circulating liposomes, ziyuglycoside Ihttps://www.dovepress.com/tpgs-modified-long-circulating-liposomes-loading-ziyuglycoside-i-for-e-peer-reviewed-fulltext-article-IJNmyelosuppressiontherapytpgslong-circulating liposomesziyuglycoside i
spellingShingle Song T
Wang H
Liu Y
Cai R
Yang D
Xiong Y
TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
International Journal of Nanomedicine
myelosuppression
therapy
tpgs
long-circulating liposomes
ziyuglycoside i
title TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
title_full TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
title_fullStr TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
title_full_unstemmed TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
title_short TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression
title_sort tpgs modified long circulating liposomes loading ziyuglycoside i for enhanced therapy of myelosuppression
topic myelosuppression
therapy
tpgs
long-circulating liposomes
ziyuglycoside i
url https://www.dovepress.com/tpgs-modified-long-circulating-liposomes-loading-ziyuglycoside-i-for-e-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT songt tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression
AT wangh tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression
AT liuy tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression
AT cair tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression
AT yangd tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression
AT xiongy tpgsmodifiedlongcirculatingliposomesloadingziyuglycosideiforenhancedtherapyofmyelosuppression